Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis
Clinical trial NCT03931915 · COMPLETED
Trial details
- NCT number
- NCT03931915
- Sponsor
- ASKA Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-08
- Primary completion
- 2020-06-12
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.